Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian share markets open weak
Thu, 1 Nov 09:30 am

Asian stock markets have opened the day on a mixed note with stock markets in China (up 1.8%) and Hong Kong (up 0.5%) leading the gains in the region. However, markets in South Korea (down 0.7%) and Indonesia (down 0.6%) have opened in the red. The Indian equity markets have opened the day on a weak note. Stocks in the FMCG and energy space are leading the losses. However, consumer durables and auto stocks are trading firm.

The Sensex today is down by around 36 points (0.2%), while the NSE-Nifty is down by around 12 points (0.2%). However, both Mid and small cap stocks have opened in the green with the BSE Mid Cap and BSE Small Cap indices up by around 0.1% each. The rupee is trading at Rs 53.87 to the US dollar.

Consumer durable stocks have opened the day on a firm note with Titan Industries Ltd and Videocon Industries Ltd. leading the gains. Titan Industries Ltd has announced its results for the second quarter of financial year 2013 (2QFY13). The company reported a 21.4% year on year (YoY) growth in the net profits during the quarter. The total revenues for the quarter registered an increase of 8.6% YoY. For the first half of FY13 (1HFY13), the growth in the net profits came at 15.2% YoY. As per the management, all the business segments recorded good growth in revenues during the quarter on a year on year basis. The revenues from the jewellery business recorded a growth of 5.7% YoY. Other businesses like eyewear and precision engineering grew by 49.4% YoY during the quarter. As on September 30, 2012 the company has a strong retail chain of 879 stores with a retail area crossing 11.2 lakh square feet nationally for all its brands. The management plans to introduce several new products and opening many stores early in third quarter of FY13

Indian pharma stocks have opened the day on a mixed note with Panacea Biotech Ltd and Biocon Ltd leading the gains. However, Sun Pharma Ltd and Elder Pharma Ltd were facing selling pressure. Sanofi India Ltd has announced its results for the third quarter of calendar year 2013 (3QCY13). The total income during the quarter registered a growth of 25.1% on year on year (YoY) basis. The net profits for the quarter declined by 6.4% YoY. The decline is mainly on account of an increase in the cost of materials.

It is also on account of higher amortization costs relating to brands, technical knowhow and goodwill acquired from Universal Medical. The bottomline was also adversely impacted on account of a fall in the other income.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian share markets open weak". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.